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Abstract: Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 
(FAU) gene is down-regulated in human prostate, breast and ovarian cancers. Moreover,  
its dysregulation is associated with poor prognosis in breast cancer. Sponges (Porifera) are 
animals without tissues which branched off first from the common ancestor of all metazoans. 
A large majority of genes implicated in human cancers have their homologues in the 
sponge genome. Our study suggests that FAU gene from the sponge Suberites domuncula 
reflects characteristics of the FAU gene from the metazoan ancestor, which have changed 
only slightly during the course of animal evolution. We found pro-apoptotic activity of 
sponge FAU protein. The same as its human homologue, sponge FAU increases apoptosis 
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in human HEK293T cells. This indicates that the biological functions of FAU, usually 
associated with “higher” metazoans, particularly in cancer etiology, possess a biochemical 
background established early in metazoan evolution. The ancestor of all animals possibly 
possessed FAU protein with the structure and function similar to evolutionarily more 
recent versions of the protein, even before the appearance of true tissues and the origin of 
tumors and metastasis. It provides an opportunity to use pre-bilaterian animals as a simpler 
model for studying complex interactions in human cancerogenesis. 
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1. Introduction 
The evolution of cancer is still not fully understood. However, it is known that the genes of cellular 
cooperation that evolved along with multicellularity, when malfunctioned, contribute to cancer 
development [1]. The majority of these genes are involved not only in cell division and cell growth, 
but also in cell adhesion, apoptosis, developmental signaling pathways, recognition of self and non-self 
and differentiation of various cell types. All living animals descended from the 600 million year old 
common ancestor, including sponges and humans [2]. Sponges are the simplest animals, but despite 
the absence of tissues, their genomes contain a large majority of genes that have been implicated in 
human cancer [2]. However, the functions of these genes and biochemical characteristics of their 
products within the sponge cells remained largely unknown [3,4]. Tumors have not yet been identified 
in sponges, although computational studies have predicted that most metazoans might be prone to 
develop tumors [5]. Moreover, naturally occurring tumors have recently been described in two 
cnidarian species [6]. These findings suggest that understanding of cancer associated genes in simpler 
animals without tissues and blood vessels could help in understanding the more complex interactions 
of their homologues in higher Metazoa. 
Ribosome assembly is a complex process requiring coordinated activation of more than 200  
non-ribosomal factors, including numerous small nucleolar RNAs (snoRNAs). Their role in modification 
of ribosomal RNAs (rRNAs) was shown to be essential for the correct assembly of the ribosome [7,8]. 
Three major classes of snoRNAs include: C/D box snoRNAs (primarily guide the 2′-O-methylation of 
target rRNAs), H/ACA box snoRNAs (typically guide pseudouridylation of target rRNAs) and small 
Cajal-body-specific RNAs (scaRNAs) (typically target snoRNAs). snoRNAs are believed to be the 
most ancient non-coding RNAs (ncRNAs) [9]. Many examples of ncRNAs displaying both snoRNA 
and microRNA (miRNA) characteristics suggest a possible evolution from one type to the other [10]. 
snoRNAs are nonautonomous transposable elements that can gain additional genomic copies, usually 
by a copy-and-paste mechanism involving an RNA intermediate. These snoRNA retroposons (snoRTs), 
like Alu element, use the LINE L1 machinery for their mobilization, and probably play an important 
role in evolution of mammalian genome [11]. 
Ribosomal proteins (RPs) are an evolutionarily conserved component of ribosome in every cell of 
every organism. Analysis of 66 complete genomes revealed that 34 RPs are common to all living 
organisms [12]. Many RPs possess additional extraribosomal functions in cells. They are involved in 
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many processes within the ribosome system, surveillance of ribosome synthesis, but also in replication 
and regulation of cell growth, apoptosis and cancer [13]. Human FAU gene (Finkel-Biskis-Reilly 
murine sarcoma virus (FBR-MuSV) ubiquitously expressed) encodes the ribosomal protein S30 
(RPS30) fused with an ubiquitin-like protein FUBI [14]. Retrovirus FBR-MuSV, which contains genes 
v-fos and fox, can induce osteosarcomas in susceptible mice [15]. Fox is an antisense sequence to the 
cellular gene FAU, which indicates a putative tumor suppressor role for FAU. Moreover, the FAU 
gene is down-regulated in human breast, prostate and ovarian tumors and its down-regulation is 
strongly associated with poor prognosis in breast cancer [16–18]. Pro-apoptotic regulatory role for 
FAU has recently been described [19]. Since the failure of apoptosis is fundamental to the development 
of many cancers, regulation of apoptosis may serve as the functional background for the extraribosomal 
function of this RP. 
Our study suggests that FAU gene from the sponge Suberites domuncula probably reflects the 
characteristics of the FAU gene from metazoan ancestor that changed only slightly during animal 
evolution. FAU protein from sponge possesses pro-apoptotic activity and increases apoptosis in human 
HEK293T cells, same as its human homologue. This suggests that biological functions of FAU, 
usually associated with the origin of cancer in “higher” metazoans, possess biochemical background 
established early in metazoan evolution. Our results implicate that the ancestor of all animals 
possessed FAU protein with the structure and the function similar to its evolutionarily recent versions, 
even before the appearance of true tissues and the origin of tumors and metastasis. 
2. Results and Discussion 
2.1. Structure and Evolution of Metazoan FAU Gene 
FAU gene encodes an ubiquitin-like protein (FUBI) fused to the ribosomal protein S30 (RPS30). 
This type of gene organization seems to be conserved throughout metazoan evolution (Figure 1A). 
Sponge FAU protein has 61% amino acid sequence identity (78% sequence similarity) with human 
FAU and is more similar to its homologues from human or rat, than to those from invertebrates 
Caenorhabditis elegans (47% sequence identity, 62% similarity) and Drosophila melanogaster  
(50% sequence identity, 68% similarity). Both invertebrate model organisms underwent recent 
accelerated evolution [20]. Since sponge FAU changed only slightly during metazoan evolution,  
it seems to be a promising candidate to effectively reflect FAU protein structure of the ancestral 
metazoan ribosome. It is also noteworthy that FUBI domain is much less conserved than RPS30. 
However, G–G dipeptide motif, which participates in bond formation between ubiquitin and lysine 
residues of target proteins, is conserved in all analyzed metazoans (Figure 1A). As already observed in 
human FAU, none of the lysine residues which serve as sites for polyubiquitin chain formation, are 
present in any of the analyzed FAU homologues (Figure 1A). This indicates that FUBI is unlikely to 
have an analogous role to ubiquitin in protein degradation and that this diverse role was probably 
established early in metazoan evolution. 
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Figure 1. (A) Multiple sequence alignment of FAU proteins from representative species 
(Homo sapiens (Hs), Rattus norvegicus (Rn), Haliaeetus leucocephalus (Hl),  
Anolis carolinensis (Ac), Xenopus laevis (Xl), Danio rerio (Dr), Apis mellifera (Am), 
Metaseiulus occidentalis (Mo), Drosophila melanogaster (Dm), Branchiostoma floridae 
(Bf), Strongylocentrotus purpuratus (Sp), Ciona intestinalis (Ci), Caenorhabditis elegans 
(Ce), Nematostella vectensis (Nv), Trichoplax adhaerens (Ta), Amphimedon queenslandica 
(Aq), Monosiga brevicollis (Mb)). G–G dipeptide motif and missing lysine residues which 
serve as sites for polyubiquitin chain formation are marked with arrows and asterisks, 
respectively; red = 100%, blue = 80% and yellow = 60% identity; (B) Over-represented 
motifs in sponge ribosomal protein gene (RPG) promoters and promoter sequence of 
sponge FAU with indicated translational start site (marked with yellow rectangle), 
transcription start site (TSS, marked with arrow) and transcription factor binding sites and 
terminal 5′-terminal oligopyrimidine (TOP) tract (marked with rectangles). 
Synchronized expression of ribosomal protein genes (RPGs), driven by the promoters of similar 
strength, ascertains equimolecular amount of ribosomal proteins in the cell, which is prerequisite for 
the ribosome assembly [21,22]. Human over-represented motifs in RPG promoters are identified as 
targets for YY1, NRF1, c-Myc and SP1 transcription factors [21]. The 5′-terminal oligopyrimidine 
(TOP) tract in human RP transcripts is also known to be essential for the control of gene expression,  
at both the transcriptional and the translational levels [23,24]. To test which elements are present  
in the FAU promoter, we compared over-represented motifs in RPG promoters of the sponge 
Amphimedon queenslandica with FAU sequence. In the majority of analyzed human RPG promoters, 
YY1 motifs were found downstream of the transcription start site (TSS) [25]. This motif is also present 
downstream in the sponge FAU (p = 3.00 × 10−7) (Figure 1B). Two SP1 and one NRF1 binding sites 
were found upstream of the TSS (p = 4.08 × 10−7, p = 1.39 × 10−7, p = 7.10 × 10−7, respectively), 
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while E-box palindromic core CACGTG was also identified in FAU promoter (p = 3.12 × 10−6). 
Among many transcription factors that recognize the E-box, oncoprotein c-Myc (MYC) is known to 
bind to it [26]. c-Myc enhances ribosomal biogenesis by up-regulating transcription mediated by all 
three RNA polymerases [27]. This implies possible participation of the FAU protein in the analogous  
c-Myc-enhanced ribosomal biogenesis established early in metazoan evolution. The TSS was 
identified in TOP (Figure 1B). The TOP motif has a dual regulatory function in vertebrates. It is a part 
of a cis-regulatory element in transcriptional regulation and has a role at the translational level [23,24]. 
In certain physiological conditions, it inhibits binding of the translational regulatory proteins or the 
translational machinery to the mRNA [28]. The presence of TOP and all other elements in sponge 
FAU promoter indicates that the foundations of the human FAU cis-regulation were established early 
in metazoan evolution. 
Multiple sequence alignment of FAU gene orthologues was used to characterize intron dynamics by 
comparing the intron positions (Figure 2). Most of the positions, phases, and the number of introns in 
FAU genes were not significantly changed from sponge to human (Figure 2). The most conserved 
intron position separates the UBQ from RPS30 domain in FAU and varies from 25 to 3339 bp. The 
average value of sponge RPG intron length is 164 bp [29], while human RPGs have significantly 
longer introns, with the average length of 760 bp [30]. Transposable element insertions play an 
important role in the evolution of intron size [31]. Therefore, we searched for over-represented 
elements in FAU introns. 
2.2. Identification of snoRNAs in FAU Introns of Sponges 
The accumulating genomic data strongly confirm the tendency of snoRNAs to colonize RPGs and 
ribosome related genes in eukaryotes [32]. The total set of 16 introns in FAU gene from eight sponges 
produced four candidate H/ACA snoRNAs. After a more detailed analysis, we were able to identify 
three snoRNAs that match a sequence motif of known snoRNAs available on Rfam, the snOPY 
database and the snoRNA-LBME database. This snoRNA is the sponge orthologue of the human 
SNORA62 (E2) (Figure 3A). SNORA62 is predicted to guide the pseudouridylation of uridine residues 
at the position 3830 and 3832 in human 28S rRNA [33]. This target sequence of 28S rRNA is highly 
conserved between human and analyzed sponges (Figure 3B). The sponge SNORA62 pseudouridylation 
guide sequence, as well as the H- and ACA-boxes, are also well conserved (Figure 3A). Its expression 
was verified experimentally (Figure 3C). Phylogenetic analysis of SNORA62/SNORA6 is presented in 
Figure 3D. The SNORA62 and SNORA6 share the same host gene in vertebrates and SNORA6 
probably arose by cis-duplication of SNORA62. The SNORA62 homologues from sponges clearly 
group together and reflect the characteristics of snoRNA ancestral to this snoRNA family, before the 
duplications and diversifications within the metazoan lineage. snoRNAs are mobile genetic elements, 
often transferred through retrotransposition, and can therefore participate in diversification and 
enrichment of transcriptomes through various mechanisms such as intron/exon gain/loss [34]. It is 
known that snoRNAs can change their genomic location within relatively short vertebrate evolutionary 
time scales [35]. Since all of examined RPG intron positions were conserved in three Suberites 
species, it was presumed that on this shorter evolutionary time scale, mobility of snoRNAs is not a 
significant factor that determines intron dynamics [29]. However, we found that within the same genus 
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(Suberites), SNORA62 can change its genomic location. In S. pagurorum, S. domuncula and S. ficus 
this snoRNA is present in the same intron, but apparently is missing in the same conserved intron in  
S. massa (Figure 2). Our results indicate that RPG introns are more dynamic than previously 
documented and that mobility of snoRNAs plays an important role in RPG (and FAU) evolution even 
on shorter evolutionary time scales. 
 
Figure 2. Intron-mapping of FAU genes from representative species. White triangles 
indicate positions of the introns and gray triangles indicate presence of SNORA62. The 
number within triangle denotes the intron phase and the number in brackets intron length. 
The thin line indicates the 5′ UTR region. 
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Figure 3. (A) SNORA62 conserved in the last introns of the FAU gene in S. domuncula,  
S. ficus and S. pagurorum. All essential snoRNA elements are conserved and a putative 
pseudouridylation (PU) guide site is designated; red = 100%, blue = 80% and yellow = 60% 
identity; (B) Target sites of SNORA62 are conserved in sponges and marked with psi;  
(C) Experimental verification of transcription of sponge SNORA62. Polyadenylated snoRNAs 
were amplified, cloned and sequenced; (D) Maximum likelihood (ML) phylogenetic tree of 
snoRNAs from representative species. Bootstrap values for ML are given above and 
MCMC below the line. The scale bar indicates the genetic distance of the branch lengths. 
The other snoRNA shows stable secondary structure with conserved snoRNA parts (Figure S1). In 
the first intron of FAU gene of the sponge Rhizaxinella pyrifera, a single snoRNA with a potential 
target rRNA was found (Figure S1). This target is not conserved in humans nor has it yet been 
described as a pseudouridylation site, so we can only speculate about the possible function of  
this snoRNA. 
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2.3. Subcellular Localization of Sponge FAU 
RPs are mainly cytoplasmic, being incorporated into translating ribosomes, but they can be found, 
at least transiently, in the nucleus [36]. As mentioned before, RPs have non-ribosomal functions when 
they are off-ribosomal subunits. We transiently transfected HEK293T and HeLa cells with GFP-FAU 
from S. domuncula and DsRed-FAU from human and analyzed the cells 48 hours post transfection 
using confocal laser scanning microscopy. Proteins show the same localization pattern in both cell 
types. Both human and sponge proteins exhibit the same subcellular localization (Figure 4A). Proteins 
are dispersed throughout the cytoplasm rather than being associated with a specific cytoplasmic 
organelle (Figure 4B,C). Although the signals are present mainly in the cytoplasm, portions can also be 
clearly observed in the nuclei (Figure 4A). This result matches the finding of the previous study, where 
subcellular localization of Drosophila RPS30 was analyzed [36]. It has been observed that a fraction of 
RPS30 is localized in the nucleus and is associated with transcription sites. We presume that, 
according to cellular localization, extraribosomal functions of FAU at transcription sites were already 
present in ancestor of all metazoans and remained conserved throughout the evolution. 
 
Figure 4. (A) Subcellular localization of sponge and human FAU. HeLa cells transiently 
transfected with sponge (Sd) pEGFP-FAU (green fluorescence), human (Hs) pDsRed-FAU 
(red fluorescence); (B) pECFP-Golgi (cyan) and (C) pECFP-mitochondria (cyan). The 
overlay (yellow) shows colocalization of the human and sponge homologs in panel A.  
Scale bar = 10 μm. 
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Figure 5. Protein blot validation of sponge Flag-FAU expression and the relative growth 
rates assessed by CellTiter-Glo assay of HEK293T (A) and HeLa cells (B); Activities of 
caspase were measured by a Caspase-Glo 3/7 assay kit and by cleavage of caspase substrate 
PARP in HEK293T (C) and HeLa cells (D) transfected with pcDNA3-FAU or empty 
vector pcDNA3. Data are representative of three independent experiments (* p < 0.05). 
2.4. Overexpression of Sponge FAU in Human Cell Lines 
Transient transfection with human pcDNA3-FAU increased apoptosis and decreased short-term cell 
viability in HEK293T, Jurkat and CEM cell lines [19]. To test whether these functions of FAU protein 
were established early in metazoan evolution, we transfected HEK293T and HeLa cell lines with 
sponge pcDNA3-FAU. The growth rate of cells was evaluated at different time points after transfection, 
to determine whether overexpression of sponge FAU affects cell proliferation. Transfection markedly 
increased Flag-FAU levels (Figure 5A,B). Empty vector pcDNA3 was used as control. Subsequently, 
the proliferation of pcDNA3-FAU-transfected HEK293T cells was decreased 1.44-fold (p = 0.008) 
when compared to cells with pcDNA3 control (Figure 5A). Cell viability decreased by 30.1% 72 h 
post-transfection compared to cells possessing the control vector. Interestingly, these effects were not 
observed in HeLa cancer cell line (Figure 5A). To further investigate the mechanism underlying the 
observed, we measured caspase-3 and -7 activities in transfected cell lines. pcDNA3-FAU-transfected 
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HEK293T cells show 1.31-fold (p = 0.014) increased caspase activity as compared to pcDNA3 
transfected cells (Figure 5C). However, apoptotic cells were not elevated in HeLa cell line, and neither 
the cleavage of PARP, caspase-3 substrate, was observed (Figure 5D). Interestingly, similar results 
were obtained when human Flag-FAU was overexpressed in HeLa cells (Figure S2). Our results 
indicate that pro-apoptotic activity of FAU was established early in metazoan evolution, but appears to 
be cell type specific as its expression leads to efficient apoptosis in HEK293T but not in HeLa cell 
line. Since both human and sponge FAU do not activate caspases in HeLa cells significantly, but both 
activate caspases in HEK293T cells, we believe that the mechanism underlying this effect was already 
present in metazoan ancestor. It was proposed that Bcl-G plays an essential down-stream role in 
mediating the pro-apoptotic activity of FAU [19]. The molecular mechanisms of apoptosis regulation 
by FAU remain to be elucidated, but possibly include FUBI-mediated targeting of Bcl-G and/or 
modulation of the interaction of Bcl-G with other constituents of the cellular apoptotic machinery 
(caspases for example) [19]. Although down-regulation of Bcl-G inhibits apoptosis induced by FAU, 
basal apoptosis rates are higher in certain cellular contexts [19]. However, this effect has not been 
observed in human breast cancer and prostate cell lines [16,17]. This indicates that in certain cell lines, 
Bcl-G can have anti-apoptotic effects, in addition to the pro-apoptotic activity. Moreover, mouse  
Bcl-G is expressed in a range of epithelial, as well as in dendritic cells and its loss does not appear to 
affect any of these cell types [37]. This intriguing contrast in the effects of FAU/Bcl-G on cell fate in 
different cellular contexts presents attractive possibilities for the development of novel therapies for 
cancers and could be used for targeted elimination of cancer cells. 
From all presented data we can conclude that the structure and the functions of the recent FAU gene 
were established early in metazoan lineage. Tumor suppressor gene function of FAU probably arose 
before tumor appearance. As sponges do not possess tissues and organs, formation of tumors within 
them is unlikely. It seems that tumors evolved in parallel with the development of true tissues and 
organs, yet the extraribosomal functions of RPs were probably established in the metazoan ancestor 
well before the Cambrian explosion, i.e., before the appearance of diverse groups of multicellular 
animals. Other highly sophisticated extraribosomal functions of RPs, involved in the origin of cancer 
and metastasis, evolved together with the appearance of different cell types, tissues and organs. 
Whereas synchronized cis-regulation of RPGs needs to be conserved for equimolecular presence of 
RPs in the metazoan cell, the evolution of RPGs together with the extraribosomal functions of RPs on 
shorter evolutionary time scale is probably driven by snoRNAs. snoRNAs can promote, but also 
suppress tumor development [38]. Numerous studies already provided evidence for the functional 
importance of snoRNAs in cancerogenesis [39,40]. Our results show that SNORA62 is found in FAU 
gene in the subset of sponges from the genus Suberites, which suggests its dynamic and fast evolving 
nature. This snoRNA is located in the human ribosomal protein gene SA (RPSA). Both host RPGs 
possess an extraribosomal function involved in the maintenance of cellular viability through the 
caspase-dependent regulation of apoptosis [19,41]. Interestingly, SNORA62 is the most upregulated 
gene in diallyl sulfide (DAS)-induced apoptosis in HeLa cells, as a part of p53, mitochondria- and 
caspase- pathways [42]. It would be interesting to test whether this snoRNA can act as an oncogene 
like SNORA42 [43], or tumor suppressor like U50 snoRNA [44] and if these functions interfere and 
modulate similar functions of its host genes. The number of ncRNA is exceedingly lower in basal 
metazoans than in “higher” animals, which may indicate that metazoan complexity correlates with an 
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increasing number of ncRNAs [45]. If SNORA62 can modulate apoptotic effect of its host genes, it 
will provide new strategies for targeting FAU. In the longer term, the development of techniques for 
the manipulation of snoRNAs may also be productively directed towards the manipulation of genes 
involved in cancerogenesis for cancer therapy. Analyses of sponge FAU gene presented in our paper 
provides the opportunity to determine direction for further investigation of FAU and evaluate its 
potential for cancer treatment. Undoubtedly, sponges could be used as an informative model in cancer 
research, not only in terms of targeting genes involved in cancerogenesis by snoRNAs, but also in 
targeting snoRNAs themselves. In order to evaluate their potential for cancer treatment, further 
investigation of highly conserved and mobile snoRNAs found in the metazoan common ancestor  
is needed. 
3. Experimental Section 
3.1. Materials 
Live specimens of the sponge Suberites domuncula (Porifera, Demospongiae, Tetractinomorpha, 
Hadromerida, Suberitidae) and Sycon raphanus (Porifera, Calcarea, Calcaronea, Leucosolenida, 
Sycettidae) were collected in the Northern Adriatic Sea near Rovinj, Croatia, and stored at −80 °C. 
Specimens of Oopsacas minuta (Porifera, Hexactinellida, Hexasterophora, Lyssacinosida, Leucopsacidae) 
were collected in the cold water pit in the Middle Adriatic and specimens of Rhizaxinella pyrifera 
(Porifera, Demospongiae, Tetractinomorpha, Hadromerida, Suberitidae) were collected in the Middle 
Adriatic Pit, around 200 m depth and stored in 96% EtOH. Suberites ficus and Suberites pagurorum 
were collected in Ireland, while Suberites massa in the English Channel. 
3.2. Sequence Analyses 
Homology searches and sequence retrievals were done using BLAST (NCBI, NIH, Bethesda, MD, 
USA: http://www.ncbi.nlm.nih.gov). Sequences were analyzed using Lasergene (DNAStar, Madison, 
WI, USA). Multiple sequence alignments (MSA) were performed with CLUSTALX [46]. The exact 
position and the phase of each intron were verified by manual inspection and statistical data were 
extracted from GeneDoc (http://www.psc.edu/biomed/genedoc). 
Over-represented motifs were searched using MEME [47], as described earlier [22]. Statistical 
significance of the motif (E-value) and p-value (statistical significance of predicted sites in FAU) were 
extracted from MEME. The location of transcription factor binding sites relative to the transcription 
start site was also extracted from MEME results for FAU sequence within a set of sequences with the 
same identified motif. Obtained motifs were then compared using TOMTOM [48] against the 
TRANSFAC database of known motifs [49]. 
3.3. Isolation of Genomic DNA and Sequencing of FAU Gene 
For genomic DNA preparation, sponge specimens were cut into pieces, frozen in liquid  
nitrogen and grounded to fine powder from which total DNA was isolated using the Genomic DNA 
Purification kit (QIAGEN, Redwood City, CA, USA). Sponge FAU gene was amplified by PCR, using 
LA Taq DNA polymerase (Takara, Japan) and primers specific for ends of the coding sequence of: 
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Demospongiae (5′-GCAAGTTTTCGTACAAGGAGGGGC-3′ and 5′-GGTGCATTTGAGTTTGGTC 
CAC-3′), Hexactinellida (5′-ATGCAAGTGTTTGCACAAAC-3′ and 5′-CTAACTAGCTGAGTTTGA 
G-3′) and Calcarea (5′-CAGATTTTCATTCAGGCCCAGGC-3′ and 5′-GCGTTAGAGTTGGGTC-3′). 
The amplified fragments were separated on a 0.8% agarose gel, purified and cloned into the pGEM-T 
vector (Promega, Madison, WI, USA). Positive clones were sequenced using T7/pUC primers. 
3.4. Isolation and Characterization of Small RNAs 
snoSeeker was used to identify snoRNAs in introns of FAU genes [50]. Rfam [51], snOPY 
(http://snoopy.med.miyazaki-u.ac.jp/) and the snoRNA-LBME databases [52] were used to check 
whether snoRNAs match to any of the known snoRNAs’ motifs. The secondary structure of snoRNA 
was computed using the RNAfold program of the Vienna RNA Package [53]. Isolation of small RNAs 
from sponge was described previously [29]. In brief, fresh specimens of S. domuncula were cut into 
pieces, frozen in liquid nitrogen and grounded to a fine powder. mirPremier microRNA Isolation Kit 
(Sigma, St. Louis, MO, USA) was used, according to the manufacturer’s protocol for plant tissue. 
Polyadenylation was performed by incubation with E. coli Poly(A) Polymerase (BioLabs). Poly(A) 
tailing reaction mixture was then reverse transcribed using the SuperScript II Reverse Transcriptase 
(Invitrogen, Waltham, MA, USA) and a modified poly-d(T) primer (5′-GCGTAAGTGA 
CTAGCGTGTTTTTTTTTTTTVN-3′). The resulting cDNA was used for PCR with a reverse primer  
(5′-GCGTAAGTGACTAGCGTG-3′) and forward primer specific for predicted SNORA62  
(5′-CCCCATAGTGTTTGTTAGTAGC-3′). The product was cloned into the pGEM-T vector (Promega). 
Positive clones were sequenced using the ABI PRISM BigDye Terminator v3.1 Ready Reaction Cycle 
Sequencing Kit and T7/pUC primers. 
For phylogenetic analyses, multiple alignments were performed with CLUSTALW Ver. 1.6 [54]. 
Aligned sequences were imported into MEGA version 6 [55], and analyzed by Maximum Likelihood 
(ML), while the Bayesian MCMC analysis was conducted in MrBayes v. 3.1.2. [56]. Bootstrap tests 
were performed with 1000 replicates. The model for ML analysis was selected using Modeltest 3.7 and 
the Akaike Information Criterion (AIC) [57], which indicated Hasegawa-Kishino-Yano model (I + G) [58]. 
3.5. Cell Culture 
Human HeLa cell line (ATCC) and HEK293T cell line were cultured in L-glutamine DMEM 
(Invitrogene) supplemented with 10% fetal bovine serum (FBS, Invitrogene) and GA-1000 (30 mg/mL 
Gentamicin and 15 µg/mL Amphotericin) (Lonza, Basel, Switzerland) at a 1:1000 ratio in humidified 
chamber with 5% CO2 at 37 °C. 
3.6. Plasmid Constructions 
Eukaryotic expression vector pcDNA3 (Invitrogen) was digested with BamHI and EcoRI. The 
insert containing the FLAG sequence and sponge FAU was cloned using these sets of primers: 5′-
GTCTAGGGATCCACGAGATGGACTACAAGGACGACGACGATAAGATGCAAGTTTTCGTA-3′ 
and 5′-CTAGACGAATTCTCATCACTGAGGTGCATTTG-3′, and human FAU using: 5′-
GTCTAGGGATCCACGAGATGGACTACAAGGACGACGACGATAAGATGCAGCTCTTTGTC-3′ 
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and 5′-CTAGACGAATTCTTATTAAGAGTTGGCATTGG-3′ For localization assay, sponge FAU 
was cloned in fusion with GFP using pEGFP-C1 (XhoI/BamHI restriction sites) with the following set 
of primers: 5′-CCACTCGAGCTATGCAAGTTTTCGTACAAGG-3′ and 5′-GACGGATCCTCAT 
CACTGAGGTGCATTTG-3′, and human using pDsRed-C1 with 5′-CCACTCGAGCTATGCAGCT 
CTTTGTCCGCGC-3′ and 5′-ACAGGATCCTTAAGAGTTGGCATTGGGGCCC-3′ set of primers. 
3.7. Transient Transfections and Laser Scanning Confocal Microscopy 
Lipofectamine 3000 reagent (Invitrogen) was used for HeLa cells transfections, according to the 
manufacturer’s instructions. Twenty four hours before transfection 5 × 104 cells were seeded onto  
24-well culture slides containing DMEM supplemented with 10% FBS to obtain 80% confluence. 
Cells were transfected with 500 ng of plasmid DNA. Forty eight hours post transfection, the cells were 
washed with PBS pH 7.5, fixed in 4% formaldehyde, and mounted in SlowFade Diamond Antifade 
Mountant with or without DAPI (Molecular Probes, Waltham, MA, USA). 
Fluorescent images were obtained by Leica SP8 X FLIM laser scanning confocal microscopy 
equipped with HC PL APO CS2 63×/1.40 OIL objective. GFP was excited by 488 nm laser line, CFP 
using 433 nm, DAPI using 405 nm and DsRed at 560 nm laser lines. 
3.8. Immunoblotting 
The cell lysates were loaded on SDS-PAGE and electrotransferred to a PVDF Hybond-P membrane 
(Amersham Biosciences, Piscataway, NJ, USA). The membranes were incubated with anti-FLAG M2 
antibody (1:5000) (Sigma) for detection of FLAG-FAU or anti-PARP antibody (1:5000) (ab137653). 
Protein bands were visualized using chemiluminescence detection (Amersham ECL Plus, GE Healthcare, 
Parramatta, Australia). 
3.9. Cell Viability Assay 
HeLa cells were transfected as described above, trypsinized 24 h post-transfection and 103 viable 
cells suspended in 100 µL 10% FBS DMEM were added to each well of 96-well plates. HEK293T 
cells were transfected using standard calcium phosphate method [59]. Cell proliferation was measured 
using CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to the manufacturer’s 
instructions with luminometer Infinite 200 (TECAN). Concentration of ATP was measured in triplicate. 
3.10. Apoptosis Assay 
Cells were transfected as described above, trypsinized 24 h post-transfection and 5 × 103 viable 
cells suspended in 100 µL 10% FBS DMEM were seeded in 96-well culture plates. Caspase-3/7 
activity was measured using the Caspase-Glo 3/7 Assay Kit (Promega) according to the manufacturer’s 
instructions with luminometer Infinite 200 (TECAN). 
3.11. Statistical Analyses 
Statistical analysis was performed using Student’s t-test. Probabilities of less than 0.05 were 
considered statistically significant. 
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